Literature DB >> 7747501

New antiepileptic drugs for the treatment of childhood epilepsies.

J S Hahn.   

Abstract

The Council on Scientific Affairs of the California Medical Association presents the following epitomes of progress in pediatrics. Each item, in the judgment of a panel of knowledgeable physicians, has recently become reasonably firmly established, both as to scientific fact and clinical importance. The items are presented in simple epitome, and an authoritative reference, both to the item itself and to the subject as a whole, is generally given for those who may be unfamiliar with a particular item. The purpose is to assist busy practitioners, students, researchers, and scholars to stay abreast of progress in medicine, whether in their own field of special interest or another. The epitomes included here were selected by the Advisory Panel to the Section on Pediatrics of the California Medical Association, and the summaries were prepared under the direction of Susan B. Conley, MD, and the panel.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7747501      PMCID: PMC1022774     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  4 in total

Review 1.  New antiepileptic drugs.

Authors:  C L Harden
Journal:  Neurology       Date:  1994-05       Impact factor: 9.910

2.  New antiepileptic drugs already registered.

Authors:  P Wolf
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

Review 3.  Antiepileptic drugs in development: prospects for the near future.

Authors:  I E Leppik
Journal:  Epilepsia       Date:  1994       Impact factor: 5.864

Review 4.  The role of vigabatrin in the management of infantile epileptic syndromes.

Authors:  R E Appleton
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.